We are live on ! Find out more
JIR

James Investment Research Portfolio holdings

AUM $984M
1-Year Est. Return 36.03%
This Fund
S&P 500
This Quarter Est. Return
-11.16%
1 Year Est. Return
+36.03%
3 Year Est. Return
+106.79%
5 Year Est. Return
+132.49%
10 Year Est. Return
+460.95%
AUM
$1.61B
AUM Growth
-$831M
Cap. Flow
-$524M
Cap. Flow %
-32.62%
Top 10 Hldgs %
18.6%
Holding
932
New
148
Increased
125
Reduced
419
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 12.38%
2 Consumer Discretionary 12.33%
3 Industrials 10.73%
4 Financials 9.34%
5 Healthcare 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFLO icon
176
iShares Treasury Floating Rate Bond ETF
TFLO
$6.68B
$1.59M 0.1%
31,581
-5,692
-15% -$286K
DNR
177
DELISTED
Denbury Resources, Inc.
DNR
$1.59M 0.1%
928,010
+524,445
+130% +$1.8M
TNET icon
178
TriNet
TNET
$3.23B
$1.58M 0.1%
37,557
+5,249
+16% +$242K
EGL
179
DELISTED
Engility Holdings, Inc.
EGL
$1.56M 0.1%
54,729
-26,774
-33% -$834K
VTLE
180
DELISTED
Vital Energy
VTLE
$1.54M 0.1%
21,299
+4,059
+24% +$426K
GS icon
181
Goldman Sachs
GS
$303B
$1.52M 0.09%
9,120
-18,531
-67% -$3.74M
GHDX
182
DELISTED
Genomic Health, Inc.
GHDX
$1.52M 0.09%
23,645
-6,845
-22% -$480K
FITB
183
Fifth Third Bancorp
FITB
$50B
$1.52M 0.09%
64,420
-73,915
-53% -$1.94M
COF icon
184
Capital One
COF
$133B
$1.51M 0.09%
19,925
-5,135
-20% -$445K
GAP
185
The Gap Inc
GAP
$7.61B
$1.5M 0.09%
58,365
-25,024
-30% -$669K
CIM
186
Chimera Investment
CIM
$961M
$1.49M 0.09%
27,835
+8
+0% +$438
TRTN
187
DELISTED
Triton International Limited
TRTN
$1.49M 0.09%
47,874
-20,996
-30% -$677K
FL
188
DELISTED
Foot Locker
FL
$1.47M 0.09%
27,545
-22,160
-45% -$1.11M
ESNT icon
189
Essent Group
ESNT
$6.25B
$1.45M 0.09%
42,395
-21,315
-33% -$815K
QVCGA
190
DELISTED
QVC Group Inc Series A
QVCGA
$1.44M 0.09%
1,520
-935
-38% -$983K
TRV icon
191
Travelers Companies
TRV
$77.4B
$1.44M 0.09%
12,000
-650
-5% -$81.4K
CBRE icon
192
CBRE Group
CBRE
$43.5B
$1.44M 0.09%
35,846
-4,038
-10% -$167K
MNK
193
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.43M 0.09%
90,420
+14,795
+20% +$369K
ARCB icon
194
ArcBest
ARCB
$3.11B
$1.43M 0.09%
41,675
-33,035
-44% -$1.28M
HUM icon
195
Humana
HUM
$47B
$1.42M 0.09%
4,962
-1,931
-28% -$612K
OMF icon
196
OneMain Financial
OMF
$7.26B
$1.41M 0.09%
58,234
-14,428
-20% -$410K
ALSN icon
197
Allison Transmission
ALSN
$10.6B
$1.41M 0.09%
32,029
-14,884
-32% -$690K
LADR
198
Ladder Capital
LADR
$1.25B
$1.4M 0.09%
90,530
+45,375
+100% +$770K
GLD icon
199
SPDR Gold Trust
GLD
$153B
$1.4M 0.09%
11,532
-2,614
-18% -$304K
SC
200
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$1.39M 0.09%
79,221
-34,351
-30% -$638K

Similar funds

James Investment Research's Q4 2018 Portfolio in Review

As of Q4 2018, James Investment Research held 932 positions worth $1.61B, down 34% from $2.44B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

James Investment Research withdrew a net $524M in Q4 2018, closing 115 positions and reducing 419 holdings. Its most notable exit was Aetna Inc, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, James Investment Research opened a new position in California Resources Corporation worth $1M.

  • James Investment Research's largest Q4 2018 buy was California Resources Corporation: 58,700 shares worth $1M.
  • James Investment Research added most to iShares 7-10 Year Treasury Bond ETF in Q4 2018, an estimated $35.8M increase.
  • James Investment Research's biggest Q4 2018 reduction was iShares Floating Rate Bond ETF, cutting an estimated $30.3M.
  • James Investment Research fully exited Aetna Inc in Q4 2018, selling an estimated $12.8M.
  • James Investment Research's ten largest holdings make up 19% of its $1.61B portfolio in Q4 2018.
  • James Investment Research opened 148 new positions and closed 115 in Q4 2018.
  • James Investment Research's portfolio value fell 34% quarter-over-quarter to $1.61B.

Based on James Investment Research's 13F filing for Q4 2018, filed 22 Jan 2019.